Antibiotics Market Size Worth $57.99 Billion By 2028 | CAGR
4.5%: Grand View Research, Inc. - Seite 3
A group of key pharmaceutical players has launched AMR Action Fund worth USD 1 billion in July 2020. This fund is expected to support the research of innovative and novel antibiotics and is formed in collaboration with the European Investment Bank, the Wellcome Trust, and the World Health Organization.
Due to the lack of commercial success for newly developed antimicrobial drugs, government and non-government bodies have adopted strategies to incentivize antibiotic drug R&D activities. For instance, the government in alliance with BARDA is supporting several companies to boost the R&D activities in new therapies for infectious diseases. BARDA has also been associated with pharmaceutical companies, such as GSK, Tetraphase, and Basilea Astra Zeneca. CARB-X is investing around USD 109 million to support the early-stage development of potential therapeutic candidates.
Grand View Research has segmented the global antibiotics market on the basis of action mechanism, drug class, and region:
- Antibiotics Action Mechanism Outlook (Revenue, USD Million, 2017 - 2028)
- Cell Wall Synthesis Inhibitors
- Protein Synthesis Inhibitors
- DNA Synthesis Inhibitors
- RNA Synthesis Inhibitors
- Mycolic Acid Inhibitors
- Others
- Antibiotics Drug Class Outlook (Revenue, USD Million, 2017 - 2028)
- Cephalosporin
- Penicillin
- Fluoroquinolone
- Macrolide
- Carbapenem
- Aminoglycoside
- Sulfonamide
- 7-ACA
- Others
- Antibiotics Regional Outlook (Revenue, USD Million, 2017 - 2028)
- North America
- U.S
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Asia Pacific
- India
- China
- Japan
- Thailand
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
Lesen Sie auch
List of Key Players of Antibiotics Market